Free Trial

Rezolute (RZLT) Stock Price, News & Analysis

Rezolute logo
$5.81 +0.24 (+4.31%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$5.70 -0.11 (-1.98%)
As of 08/8/2025 04:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Rezolute Stock (NASDAQ:RZLT)

Key Stats

Today's Range
$5.54
$5.85
50-Day Range
$4.03
$6.38
52-Week Range
$2.21
$6.64
Volume
420,647 shs
Average Volume
909,620 shs
Market Capitalization
$505.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.20
Consensus Rating
Buy

Company Overview

Rezolute Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
52nd Percentile Overall Score

RZLT MarketRank™: 

Rezolute scored higher than 52% of companies evaluated by MarketBeat, and ranked 505th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Rezolute has received a consensus rating of Buy. The company's average rating score is 3.17, and is based on 5 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Rezolute has only been the subject of 1 research reports in the past 90 days.

  • Read more about Rezolute's stock forecast and price target.
  • Earnings Growth

    Earnings for Rezolute are expected to decrease in the coming year, from ($0.93) to ($1.15) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Rezolute is -5.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Rezolute is -5.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Rezolute has a P/B Ratio of 2.65. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Rezolute's valuation and earnings.
  • Percentage of Shares Shorted

    9.63% of the outstanding shares of Rezolute have been sold short.
  • Short Interest Ratio / Days to Cover

    Rezolute has a short interest ratio ("days to cover") of 6.2.
  • Change versus previous month

    Short interest in Rezolute has recently increased by 1.45%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Rezolute does not currently pay a dividend.

  • Dividend Growth

    Rezolute does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.63% of the outstanding shares of Rezolute have been sold short.
  • Short Interest Ratio / Days to Cover

    Rezolute has a short interest ratio ("days to cover") of 6.2.
  • Change versus previous month

    Short interest in Rezolute has recently increased by 1.45%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Rezolute has a news sentiment score of 1.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.48 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Rezolute this week, compared to 3 articles on an average week.
  • Search Interest

    Only 5 people have searched for RZLT on MarketBeat in the last 30 days. This is a decrease of -29% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Rezolute to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Rezolute insiders have bought more of their company's stock than they have sold. Specifically, they have bought $4,041,196.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    18.39% of the stock of Rezolute is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    82.97% of the stock of Rezolute is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Rezolute's insider trading history.
Receive RZLT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rezolute and its competitors with MarketBeat's FREE daily newsletter.

RZLT Stock News Headlines

The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.
See More Headlines

RZLT Stock Analysis - Frequently Asked Questions

Rezolute's stock was trading at $4.90 at the start of the year. Since then, RZLT shares have increased by 18.6% and is now trading at $5.81.

Rezolute, Inc. (NASDAQ:RZLT) posted its earnings results on Tuesday, May, 13th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.22) by $0.05.

Rezolute's top institutional shareholders include Geode Capital Management LLC (1.97%), Intech Investment Management LLC (0.04%), Retireful LLC (0.02%) and Police & Firemen s Retirement System of New Jersey (0.02%). Insiders that own company stock include Young-Jin Kim, Daron Evans, Nevan C Elam, Nevan C Elam, Wladimir Hogenhuis, Wladimir Hogenhuis, Nerissa Kreher and Brian Kenneth Roberts.
View institutional ownership trends
.

Shares of RZLT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Rezolute investors own include Meta Platforms (META), NVIDIA (NVDA), PayPal (PYPL), Advanced Micro Devices (AMD), Taiwan Semiconductor Manufacturing (TSM), CrowdStrike (CRWD) and Vanguard S&P 500 ETF (VOO).

Company Calendar

Last Earnings
5/13/2025
Today
8/10/2025
Next Earnings (Estimated)
9/18/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:RZLT
CIK
1509261
Fax
N/A
Employees
40
Year Founded
N/A

Price Target and Rating

High Price Target
$15.00
Low Price Target
$9.00
Potential Upside/Downside
+110.0%
Consensus Rating
Buy
Rating Score (0-4)
3.17
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.15)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$68.46 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-70.09%
Return on Assets
-63.08%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
8.43
Quick Ratio
8.43

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.19 per share
Price / Book
2.65

Miscellaneous

Outstanding Shares
86,996,000
Free Float
70,997,000
Market Cap
$505.45 million
Optionable
Optionable
Beta
0.18

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:RZLT) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners